Ale S, Hunter E, Kelleher J
BMC Infect Dis. 2024; 24(1):1411.
PMID: 39695997
PMC: 11653803.
DOI: 10.1186/s12879-024-10271-w.
Chen Y, Bao Y, Yan M, Jin H, Yao K, Zhang C
Infect Dis Ther. 2024; 14(1):181-197.
PMID: 39663286
PMC: 11782747.
DOI: 10.1007/s40121-024-01084-0.
Grantz K, Cepeda J, Astemborski J, Kirk G, Thomas D, Mehta S
J Viral Hepat. 2024; 32(4):e13999.
PMID: 39234877
PMC: 11880348.
DOI: 10.1111/jvh.13999.
Frankova S, Uzlova N, Merta D, Pitova V, Sperl J
Life (Basel). 2023; 13(4).
PMID: 37109461
PMC: 10144836.
DOI: 10.3390/life13040932.
Robins G, Lusher D, Broccatelli C, Bright D, Gallagher C, Karkavandi M
Soc Networks. 2022; 72:108-120.
PMID: 36188126
PMC: 9504355.
DOI: 10.1016/j.socnet.2022.09.005.
Country versus pharmaceutical company interests for hepatitis C treatment.
Lothan R, Gutman N, Yamin D
Health Care Manag Sci. 2022; 25(4):725-749.
PMID: 36001218
PMC: 9399601.
DOI: 10.1007/s10729-022-09607-2.
Extent and implications of omitted ties on network measures in a longitudinal social network survey of people who use drugs.
Upton E, Rudolph A, Ward P, Havens J, Young A
Drug Alcohol Depend. 2022; 238:109554.
PMID: 35850026
PMC: 9514791.
DOI: 10.1016/j.drugalcdep.2022.109554.
A review of network simulation models of hepatitis C virus and HIV among people who inject drugs.
Bellerose M, Zhu L, Hagan L, Thompson W, Randall L, Malyuta Y
Int J Drug Policy. 2019; 88:102580.
PMID: 31740175
PMC: 8729792.
DOI: 10.1016/j.drugpo.2019.10.006.
Hepatitis C virus modelled as an indirectly transmitted infection highlights the centrality of injection drug equipment in disease dynamics.
Miller-Dickson M, Meszaros V, Almagro-Moreno S, Ogbunugafor C
J R Soc Interface. 2019; 16(158):20190334.
PMID: 31480919
PMC: 6769301.
DOI: 10.1098/rsif.2019.0334.
Injection drug network characteristics as a predictor of injection behaviour.
Spelman T, Sacks-Davis R, Dietze P, Higgs P, Hellard M
Epidemiol Infect. 2019; 147:e173.
PMID: 31063105
PMC: 6518653.
DOI: 10.1017/S095026881900061X.
Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment.
Khan B, Duncan I, Saad M, Schaefer D, Jordan A, Smith D
PLoS One. 2018; 13(11):e0206356.
PMID: 30496209
PMC: 6264850.
DOI: 10.1371/journal.pone.0206356.
Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies.
Pitcher A, Borquez A, Skaathun B, Martin N
J Theor Biol. 2018; 481:194-201.
PMID: 30452959
PMC: 6522340.
DOI: 10.1016/j.jtbi.2018.11.013.
Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour.
Scott N, Stoove M, Wilson D, Keiser O, El-Hayek C, Doyle J
J Int AIDS Soc. 2018; 21(1).
PMID: 29314670
PMC: 5810343.
DOI: 10.1002/jia2.25059.
Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.
Zelenev A, Li J, Mazhnaya A, Basu S, Altice F
Lancet Infect Dis. 2017; 18(2):215-224.
PMID: 29153265
PMC: 5860640.
DOI: 10.1016/S1473-3099(17)30676-X.
Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.
Gonzalez S, Fierer D, Talal A
Addict Disord Their Treat. 2017; 16(2 Suppl 1):S1-S23.
PMID: 28701904
PMC: 5491232.
DOI: 10.1097/ADT.0000000000000104.
Impact of Hepatitis C Treatment as Prevention for People Who Inject Drugs is sensitive to contact network structure.
Metzig C, Surey J, Francis M, Conneely J, Abubakar I, White P
Sci Rep. 2017; 7(1):1833.
PMID: 28500290
PMC: 5431870.
DOI: 10.1038/s41598-017-01862-6.
The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study.
Cousien A, Leclerc P, Morissette C, Bruneau J, Roy E, Tran V
BMC Infect Dis. 2017; 17(1):162.
PMID: 28222681
PMC: 5320702.
DOI: 10.1186/s12879-017-2256-5.
Exploratory social network analysis and gene sequencing in people who inject drugs infected with hepatitis C virus.
Wang Y, Tan X, Zhou C, Zhou W, Peng J, Ren Y
Epidemiol Infect. 2016; 144(14):3080-3090.
PMID: 27405277
PMC: 9150418.
DOI: 10.1017/S0950268816001333.
Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections.
Fu R, Gutfraind A, Brandeau M
Math Biosci. 2016; 273:102-13.
PMID: 26775738
PMC: 5154253.
DOI: 10.1016/j.mbs.2016.01.003.
Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.
Hickman M, De Angelis D, Vickerman P, Hutchinson S, Martin N
Curr Opin Infect Dis. 2015; 28(6):576-82.
PMID: 26524330
PMC: 4659818.
DOI: 10.1097/QCO.0000000000000216.